-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Recently, a research article was published in the Journal of Clinical Endocrinology & Metabolism, an authoritative journal in the field of endocrine and metabolic diseases, which aims to clarify the use of procalcitonin (ProCT) in the prediction and treatment monitoring of medullary thyroid carcinoma (MTC) The accuracy of diagnosis
diagnosis
The researchers performed a meta-analysis of 11 clinically and statistically identical studies (n=5817 patients, 335 MTC patients), and applied HSROC and bivariate methods
Original source:
Luca Giovanella.
Procalcitonin as an alternative tumor marker of medullary thyroid carcinoma.
A meta-analysis
in this message